369. Assessing the predictive and prognostic value of the biomarker TP53 in patients with resectable colorectal liver metastases treated with and without neoadjuvant fluorouracil based chemotherapy: A p53 research group study

✍ Scribed by Pilat, N.P.; Grünberger, T.; Längle, F.L.; Mittlböck, M.; Perisanidis, B.; Kappel, S.; Wolf, B.; Kührer, I.; Mühlbacher, F.L.; Kandioler, D.

• Book ID: 126702206
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 59 KB
• Volume: 40
• Category: Article
• ISSN: 0748-7983
• DOI: 10.1016/j.ejso.2014.08.359